We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“Innovative trial designs … may be particularly useful in studies of regenerative medicine therapies to treat rare diseases,” the agency said. Read More
A Florida pharmacist convicted for his role in a huge compounding pharmacy fraud scheme was sentenced on Wednesday to 10 years in prison and ordered to pay millions in restitution. Read More
A New York union has filed a class-action lawsuit against AbbVie and seven other drugmakers, accusing them of throwing up a “patent thicket” to keep cheaper rivals to AbbVie’s blockbuster drug Humira off the market. Read More
The FDA has ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto, the company announced Wednesday. Read More
With the UK’s possible exit from the EU a little over a week away, the Medicines and Healthcare products Regulatory Agency (MHRA) released 16 new and revised guidances to cover a no-deal exit scenario. Read More
Teva Pharmaceuticals has agreed to a patent litigation settlement with Novo Nordisk that would see the generic drugmaker wait until December 2023 to begin marketing its generic version of the type 2 diabetes drug Victoza (liraglutide). Read More